Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Dare Bioscience, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +2 vs. Q3 2021
- Shares held
- 6.87M
- +2.37M (+52.5%) vs. Q3 2021
- Total value
- $13.7M
- +$6.22M (+82.6%) vs. Q3 2021
- New holders
- 9
- 14 more added
- Sold out
- 7
- 5 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DARE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $2.75M |
| Q1 2026 | 25 | $1.87M |
| Q4 2025 | 27 | $1.90M |
| Q3 2025 | 21 | $2.12M |
| Q2 2025 | 23 | $2.16M |
| Q1 2025 | 24 | $2.39M |
| Q4 2024 | 25 | $2.43M |
| Q3 2024 | 22 | $2.08M |
| Q2 2024 | 28 | $2.46M |
| Q1 2024 | 36 | $3.35M |
| Q4 2023 | 35 | $2.04M |
| Q3 2023 | 30 | $5.97M |
| Q2 2023 | 28 | $5.92M |
| Q1 2023 | 29 | $7.16M |
| Q4 2022 | 30 | $5.82M |
| Q3 2022 | 31 | $7.56M |
| Q2 2022 | 36 | $9.12M |
| Q1 2022 | 40 | $9.89M |
| Q4 2021 | 38 | $13.7M |
| Q3 2021 | 37 | $8.07M |
| Q2 2021 | 34 | $6.40M |
| Q1 2021 | 30 | $6.10M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Dare Bioscience, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 433 | $1.00K | 0.00% | +131+43.4% | Added |
| NVWM, LLC | 520 | $1.00K | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 1,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Artemis Wealth Advisors, LLC | 881 | $2.00K | 0.00% | 00.0% | Unchanged |
| Tortoise Investment Management, LLC | 750 | $2.00K | 0.00% | +750 | New |
| High Net Worth Advisory Group LLC | 1,000 | $2.00K | 0.00% | +1,000 | New |
| Edge Wealth Management LLC | 2,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 2,400 | $5.00K | 0.00% | +1,000+71.4% | Added |
| Buckingham Strategic Partners | 10,000 | $20.0K | 0.00% | +10,000 | New |
| Victory Capital Management Inc | 10,698 | $21.0K | 0.00% | +543+5.3% | Added |
| Insight Financial Services | 11,400 | $22.0K | 0.02% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 11,617 | $23.0K | 0.00% | +11,617 | New |
| United Capital Financial Advisers, LLC | 15,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 15,130 | $30.0K | 0.00% | +14,630+2,926.0% | Added |
| Advisor Group Holdings, Inc. | 16,763 | $34.0K | 0.00% | +6,000+55.7% | Added |
| XTX Topco Ltd | 20,684 | $41.0K | 0.02% | −10,103−32.8% | Reduced |
| Paradigm, Strategies in Wealth Management, LLC | 22,355 | $45.0K | 0.05% | −750−3.2% | Reduced |
| HighTower Advisors, LLC | 22,664 | $45.0K | 0.00% | +629+2.9% | Added |
| CIBC Private Wealth Group, LLC | 25,000 | $50.0K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Services Advisors, Inc. | 30,000 | $60.0K | 0.00% | +30,000 | New |
| Charles Schwab Investment Management Inc | 30,532 | $62.0K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 31,375 | $62.0K | 0.00% | +5,500+21.3% | Added |
| Two Sigma Advisers, LP | 34,400 | $69.0K | 0.00% | +34,400 | New |
| HRT Financial LP | 48,384 | $96.0K | 0.00% | +48,384 | New |
| Jane Street Group, LLC | 57,355 | $115.0K | 0.00% | −124,227−68.4% | Reduced |
| Interwest Venture Management Co | 62,065 | $124.0K | 0.07% | 00.0% | Unchanged |
| Morgan Stanley | 67,160 | $134.0K | 0.00% | +67,014+45,900.0% | Added |
| Cubist Systematic Strategies, LLC | 77,313 | $155.0K | 0.00% | +77,313 | New |
| Founders Financial Securities LLC | 103,500 | $207.0K | 0.04% | +5,000+5.1% | Added |
| Northern Trust Corp | 140,576 | $281.0K | 0.00% | +69,589+98.0% | Added |
| Gsa Capital Partners LLP | 141,843 | $284.0K | 0.04% | +129,797+1,077.5% | Added |
| Two Sigma Investments, LP | 155,128 | $310.0K | 0.00% | +142,389+1,117.7% | Added |
| State Street Corp | 161,330 | $323.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 246,612 | $493.0K | 0.00% | −8,670−3.4% | Reduced |
| BlackRock Inc. | 367,793 | $735.0K | 0.00% | +245,068+199.7% | Added |
| Geode Capital Management, LLC | 482,618 | $965.0K | 0.00% | −84,070−14.8% | Reduced |
| Marshall Wace, LLP | 1,388,562 | $2.78M | 0.01% | +1,388,562 | New |
| Vanguard Group Inc | 3,056,053 | $6.11M | 0.00% | +889,744+41.1% | Added |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −324,030−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −93,485−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −74,242−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −66,613−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −27,103−100.0% | Sold out |
| Patriot Financial Group Insurance Agency, LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Polaris Venture Management Co. V, L.L.C. | – | – | – | – | Not filed |